UFF
GMED icon

USA Financial Formulas’s Globus Medical GMED Stock Holding History

USA Financial Formulas’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395 Hold
5
– – ﹤0.01% 397
2026
Q1 		$431 Buy
+5
New +$449 ﹤0.01% 404

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

USA Financial Formulas's GMED Position: Q2 2026 in Review

USA Financial Formulas held its Globus Medical (GMED) position steady in Q2 2026 at 5 shares worth $395. The position accounts for ﹤0.01% of the portfolio, ranked #397.

USA Financial Formulas first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. The position peaked at $431 in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • USA Financial Formulas held 5 shares of Globus Medical worth $395 as of Q2 2026.
  • USA Financial Formulas left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of USA Financial Formulas's portfolio in Q2 2026, its #397 holding.
  • USA Financial Formulas first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
  • USA Financial Formulas's Globus Medical position peaked at $431 in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.